Elanco Animal Health Inc $ 25.28 0.48 (1.94%)
Volume:
4,822,257
Avg Vol (1m):
4,830,005
Market Cap $:
11.93 Bil
Enterprise Value $:
12.59 Bil
P/E (TTM):
0.00
P/B:
1.57
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.68 | ||
| Equity-to-Asset | 0.67 | ||
| Debt-to-Equity | 0.31 | ||
| Debt-to-EBITDA | 8.52 | ||
| Interest Coverage | 2.72 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 2.72 | ||
| Beneish M-Score | -2.78 | ||
Profitability Rank | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 7.64 | ||
| Net Margin % | -3.63 | ||
| ROE % | -1.72 | ||
| ROA % | -1.1 | ||
| ROC (Joel Greenblatt) % | -4.03 | ||
| 3-Year Revenue Growth Rate | 0.5 | ||
| 3-Year EBITDA Growth Rate | 25.1 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 33.6 | ||
| PB Ratio | 1.58 | ||
| PS Ratio | 3.53 | ||
| Price-to-Free-Cash-Flow | 69.47 | ||
| Price-to-Operating-Cash-Flow | 30.24 | ||
| EV-to-EBIT | -152.53 | ||
| EV-to-EBITDA | 52.42 | ||
| EV-to-Revenue | 4.51 | ||
| Current Ratio | 3.82 | ||
| Quick Ratio | 2.54 | ||
| Days Inventory | 274.28 | ||
| Days Sales Outstanding | 70.84 | ||
| Days Payable | 63.26 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 8.95 | ||
| Earnings Yield (Greenblatt) % | -0.67 |